Screening for hepatitis C virus National Coverage Determination
CMS clarified billing requirements for the screening for hepatitis C virus in adults.
Articles
Article Type
Category
Patients purchasing their own drugs or biologicals (brown bagging)
Medicare provides limited benefits for outpatient drugs. Drugs and/or biologicals purchased by the patient and taken to their...
Transcatheter aortic valve replacement (TAVR)
Important information notifying users of the requirements for approval of transcatheter aortic valve replacement (TAVR) studies.
FastTrack to Medicare coverage policies
FastTrack to Medicare coverage policies provides a hierarchy of critical resources to determine if a Medicare policy exists, and...
Proposed local coverage determination: Contractor advisory committee (CAC) meetings
Contractor advisory committee (CAC) meeting information and upcoming CAC meetings
Reporting the national drug code
Read this article for helpful information to report the national drug code on claims.
Understanding clinical trials and device coverage
Clinical trials background
What regulatory guidance addresses devices and clinical trials in the Medicare program?
For guidance...
Contractor Advisory Committee (CAC) meeting fact sheet
The CAC is used to supplement the MAC’s internal expertise and to ensure an unbiased and contemporary consideration of “state of...
NCD 110.24: Chimeric Antigen Receptor (CAR) T-cell therapy
Effective for dates of service on or after August 7, 2019, Medicare will pay claims from approved providers for administration...
Avoid negative impacts to your claims -- review billing and coding article A58918 molecular pathology and genetic testing
View this important information you must know if you bill for molecular pathology and genetic testing. This article was updated...